Israeli biomed named one of 3 top startups in world
Matricelf, which is developing a revolutionary solution for spinal cord paralysis, placed third in the 2022 Startup World Cup.
Matricelf, which is developing a revolutionary solution for spinal cord paralysis, placed third in the 2022 Startup World Cup.
Technion scientists introduce stem-cell tissue regeneration technology to rebuild bone with fewer complications.
Regenerative medicine firm Pluristem gets €50 million venture debt loan, recently treated Covid-19 patients with its placenta-derived product.
Researchers are developing complex and precise artificial tissues that can be better integrated into target organs.
Breakthrough development uses a patient’s own stomach cells, cutting the risk of an immune response to implanted organs.
Israel’s Collplant inks licensing and commercialization deal with major American biotech firm to make human organs.